Cancer statistics, 2014

  title={Cancer statistics, 2014},
  author={Rebecca L. Siegel and Jiemin Ma and Zhaohui Zou and Ahmedin Jemal},
  journal={CA: A Cancer Journal for Clinicians},
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1… 

Colorectal cancer statistics, 2014

Progress in reducing colorectal cancer death rates can be accelerated by improving access to and use of screening and standard treatment in all populations, including the most current data on incidence, survival, and mortality rates and trends.

Cancer treatment and survivorship statistics, 2014

The number of cancer survivors continues to increase due to the aging and growth of the population and improvements in early detection and treatment, and current treatment patterns for the most common cancer types are described based on information in the National Cancer Data Base and the SEER and SEER‐Medicare linked databases.

Childhood and adolescent cancer statistics, 2014

Estimates of the number of new cancer cases and deaths for children and adolescents in the United States are provided and an overview of risk factors, symptoms, treatment, and long‐term and late effects for common pediatric cancers are provided.

An assessment of progress in cancer control

This article summarizes cancer mortality trends and disparities based on data from the National Center for Health Statistics and sets the stage for a national cancer control plan, or blueprint, for the American Cancer Society goals for reducing cancer mortality by the year 2035.

An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013.

Decreases in stomach and liver cancers observed for incidence and mortality reflect the reduced attribution of infection-related factors (i.e. Helicobacter pylori and hepatitis virus).

Global trends and predictions in ovarian cancer mortality.

Favourable trends in ovarian cancer mortality are mainly due to the use of oral contraceptives in the USA and countries of the EU where OCs were introduced earlier, and predictions to 2020 indicate a further 15% decline in theUSA and 10% in the EU and Japan.

Does Survival Vary for Breast Cancer Patients in the United States? A Study from Six Randomly Selected States

Differences in breast cancer characteristics across states highlight the need to understand differences between the states that result in variances in Breast cancer survival.

Thyroid cancer mortality and incidence: A global overview

The declines in thyroid cancer mortality reflect both variations in risk factor exposure and changes in the diagnosis and treatment of the disease, while the increases in the incidence are likely due to the increase in the detection of this neoplasm over the last few decades.

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Pancreas and liver cancers are projected to surpass breast, prostate, and colorectal cancers to become the second and third leading causes of cancer-related death by 2030, respectively.

The dynamics of cancer burden in Asia.

  • K. Katanoda
  • Medicine
    Annals of translational medicine
  • 2014
A striking feature of the cancer statistics in China, as contrasted to those in the USA, was higher incidence and mortality rate of stomach, oesophagus, and liver cancers, a traditional feature of cancer in East Asia.



Trends in Breast Cancer by Race and Ethnicity

Trends in incidence, mortality, and survival rates of female breast cancer in the United States by race and ethnicity are described and continued efforts are needed to increase the availability of high‐quality mammography and treatment to all segments of the population.

Cancers with increasing incidence trends in the United States: 1999 through 2008

Rates increased for both local and advanced stage diseases for most cancer sites, and increases in incidence rates by age were steepest for liver and HPV‐related oropharyngeal cancers among those aged 54 to 64 years and for melanoma of the skin in those aged 65 years and older.

Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control

Although the decrease in overall cancer incidence and death rates is encouraging, large state and regional differences in lung cancer trends among women underscore the need to maintain and strengthen many state tobacco control programs.

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State

Breast cancer subtype analysis confirms the capacity of cancer registries to adjust national collection standards to produce clinically relevant data based on evolving medical knowledge.

Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008

Large declines in the incidence of right-sided colon tumors among individuals 50 years and older began around 2000, and increased colonoscopy utilization during the past decade may have contributed to a reduction in risk for cancers in both the right and left colorectum in the United States.

A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year

A new method is presented that uses statistical models of cancer incidence that incorporate potential predictors of spatial and temporal variation of cancer occurrence and that account for delay in case reporting and then projects these estimated numbers of cases ahead 4 years using a piecewise linear (joinpoint) regression method.

Impact of reporting delay and reporting error on cancer incidence rates and trends.

Investigating the impact of reporting delay and reporting error on incidence rates and trends for cancers of the female breast, colorectal, lung/bronchus, prostate, and melanoma found reporting-adjusted cancer incidence rates are valuable in precisely determining current cancer incidence levels and trends and in monitoring the timeliness of data collection.

Cancer Disparities by Race/Ethnicity and Socioeconomic Status

Differences in cancer incidence, mortality, and survival in relation to race/ethnicity, and census data on poverty in the county or census tract of residence are highlighted.

The role of increasing detection in the rising incidence of prostate cancer.

The recent dramatic epidemic of prostate cancer is likely the result of the increasing detection of tumors resulting from increased PSA screening, and changes in the intensity of medical surveillance is the most plausible explanation for this trend.

Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.

The black-to-white disparity in age-standardized breast cancer mortality was largely driven by the higher hazard rates of breast cancer death among black women, diagnosed with the disease, irrespective of ER expression, and especially in the first few years following diagnosis.